Sandoz Pharma A.G.
Press releases archived for reference only.
15 articles with Sandoz Pharma A.G.
Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine
Polpharma Biologics S.A. announces that it has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar.
Kit Check and Sandoz Agree to a Commercialization Collaboration That Helps Improve Hospital Medication Administration Safety
Implementation of Kit Check RFID technology enables accuracy and visibility of hospital medications, from the production line to the patient
Tilray Canada Ltd., announced that it entered into a global framework agreement to collaborate with Sandoz AG, to increase availability of high quality medical cannabis products across the world.
FDA Warns Drugmakers Over Unapproved Headache Drugs, Companies Include: Novartis Pharma AG, Sandoz GmbH, IVAX Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Limited
Savient Pharmaceuticals, Inc. Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals And Upsher-Smith Laboratories
Teva Pharmaceutical Industries Limited Announces Novartis Corporation's Sandoz Pharma A.G. Unit Seeks To Delay First FDA Approval Of Generic Zocor(R)
Sandoz Pharma A.G. Gets Precedent-Setting US Approval For Omnitrope(R) As First Follow-On Version Of A Previously Approved Recombinant Biotechnology Drug
340B Prime Vendor Program Adds Sandoz Pharmaceuticals To Growing List Of Companies Providing Low-Income Americans With Access To Antibiotic Injectibles And Oral Solid Medications